Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP
| Autor: | Kurtz, David M., Hogan, Gregory J. *, Schultz, Andre *, Kopeckova, Katerina *, Kuffer, Christian *, Blair, Derek *, Wagner, Steve *, Close, Sandra *, Diehn, Maximilian *, Chabon, Jacob J. *, Alizadeh, Ash A., Westin, Jason |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3498-3499 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|